Community Enhanced Virtual Informed Consent (CEVIC)
3. september 2026 opdateret af: Mayo Clinic
Exploring Health Communication Message Factors That Influence Cancer Research Recruitment
The goal of this clinical trial is to examine perceptions of virtual human communicators and cancer research recruitment messages.
This study will also examine how different informed consent approaches influence decisions to participate in research.
Studieoversigt
Status
Rekruttering
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
600
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: ETCH Lab
- Telefonnummer: 904-953-5375
- E-mail: ETCH@mayo.edu
Studiesteder
-
-
Florida
-
Jacksonville, Florida, Forenede Stater, 32224-9980
- Rekruttering
- Mayo Clinic in Florida
-
Ledende efterforsker:
- Janice L. Krieger, PhD
-
Kontakt:
- L. ETCH Lab
- Telefonnummer: 904-953-5375
- E-mail: ETCH@mayo.edu
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ja
Beskrivelse
Inclusion Criteria:
- Able to speak, read, or understand English sufficiently to provide informed consent
- 18 years of age or older
- White or Black
- Living in the United States
Exclusion Criteria:
- Unable to speak, read, or understand English sufficiently to provide informed consent
- Inability on the part of the patient to understand the informed consent or be compliant with the protocol
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Arm I - ICF Text Version 1
Patients receive a standard of care-based informed consent form.
Patients then complete an educational cancer messaging intervention where patients view images of virtual humans, view cancer recruitment study message frames and view images of hospital/institutional single-endorsement and multi-endorsement cancer study recruitment advertisements and rate them for credibility.
|
Hjælpestudier
Receive a text-based informed consent form
Andre navne:
Participants will view informed consent messaging presented in different formats
Andre navne:
|
|
Eksperimentel: Arm II - ICF Text Version 2
Patients receive a modified community-enhanced language text-based informed consent form.
Patients then complete an educational cancer messaging intervention where patients view images of virtual humans, view cancer recruitment study message frames and view images of hospital/institutional single-endorsement and multi-endorsement cancer study recruitment advertisements and rate them for credibility.
|
Hjælpestudier
Receive an adapted text-based informed consent form
Andre navne:
Participants will view informed consent messaging presented in different formats
Andre navne:
|
|
Eksperimentel: Arm III - ICF Video Version 1
Patients receive a video-based community-enhanced informed consent form delivered by a virtual human educator (Physician A).
The virtual human explains the informed consent form content using the language from Arm II.
Patients then complete an educational cancer messaging intervention where patients view images of virtual humans, view cancer recruitment study message frames and view images of hospital/institutional single-endorsement and multi-endorsement cancer study recruitment advertisements and rate them for credibility.
|
Hjælpestudier
Receive a video-based informed consent form delivered by virtual human #1
Andre navne:
Participants will view informed consent messaging presented in different formats
Andre navne:
|
|
Eksperimentel: Arm IV - ICF Video Version 2
Patients receive a video-based community-enhanced informed consent form delivered by a virtual human educator (Physician B).
The virtual human explains the informed consent form content using the language from Arm II.
Patients then complete an educational cancer messaging intervention where patients view images of virtual humans, view cancer recruitment study message frames and view images of hospital/institutional single-endorsement and multi-endorsement cancer study recruitment advertisements and rate them for credibility.
|
Hjælpestudier
Receive a video-based informed consent form delivered by virtual human #2
Andre navne:
Participants will view informed consent messaging presented in different formats
Andre navne:
|
|
Eksperimentel: Arm V - ICF Video Version 3
Patients receive a video-based community-enhanced informed consent form delivered by a virtual human educator (Community Member A).
The virtual human explains the informed consent form content using the language from Arm II.
Patients then complete an educational cancer messaging intervention where patients view images of virtual humans, view cancer recruitment study message frames and view images of hospital/institutional single-endorsement and multi-endorsement cancer study recruitment advertisements and rate them for credibility.
|
Hjælpestudier
Receive a video-based informed consent form delivered by virtual human #3
Andre navne:
Participants will view informed consent messaging presented in different formats
Andre navne:
|
|
Eksperimentel: Arm VI - ICF Video Version 4
Patients receive a video-based community-enhanced informed consent form delivered by a virtual human educator (Community Member B).
The virtual human explains the informed consent form content using the language from Arm II.
Patients then complete an educational cancer messaging intervention where patients view images of virtual humans, view cancer recruitment study message frames and view images of hospital/institutional single-endorsement and multi-endorsement cancer study recruitment advertisements and rate them for credibility.
|
Hjælpestudier
Receive a video-based informed consent form delivered by virtual human #4
Andre navne:
Participants will view informed consent messaging presented in different formats
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Self-efficacy (Aim 1)
Tidsramme: Baseline (immediately following intervention)
|
Assessed by 3 questions in the study-specific survey.
The questions are answered on a scale of 1 (strongly disagree) to 5=strongly agree.
Higher scores indicate greater feelings of self-efficacy.
|
Baseline (immediately following intervention)
|
|
Trustworthiness (Aim 2)
Tidsramme: Baseline (immediately following intervention)
|
Assessed by a study-specific survey asking participants to rate the intervention on a scale of 1 (untrustworthy) to 7 (trustworthy).
Higher scores indicate greater perception of trustworthiness.
|
Baseline (immediately following intervention)
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Janice L. Krieger, PhD, Mayo Clinic
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Hjælpsomme links
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
21. juli 2026
Primær færdiggørelse (Anslået)
20. juli 2027
Studieafslutning (Anslået)
20. juli 2029
Datoer for studieregistrering
Først indsendt
1. september 2026
Først indsendt, der opfyldte QC-kriterier
1. september 2026
Først opslået (Faktiske)
4. september 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
8. september 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
3. september 2026
Sidst verificeret
1. september 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 26-000655
- NCI-2026-05713 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .